MENU
SLGL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sol-Gel Technologies (SLGL) Ownership - Who owns Sol-Gel Technologies?
Sol-Gel Technologies Ltd is a dermatology company... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
7 Golda Meir Street
Phone
+972 89313429
Employees
36
Web
https://www.sol-gel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
80.26M
P/E Ratio
N/A
Total Cash
24.29M
Projected Growth
N/A
Total Debt
1.18M
Revenue
23.93M
Risk (Beta)
1.36
Dividend Yield
N/A
Total Cash/Share
8.72
Total Debt/Equity
N/A
Revenue/Share
8.59 USD as % of share price
Fundamentals
SLGL
Capitalization
80.3M
P/E Ratio
N/A
Risk (Beta)
1.36
Dividend Yield
N/A
Total Cash
24.3M
Total Cash/Share
8.72
Total Debt
1.18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
8.59%
Revenue
23.9M
ROE
N/A
Book Value
31.9M
P/B Ratio
2.52
Cash Flow
N/A
Earnings
-1.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
774K
Current Ratio
7.32
Current Revenue Per Employee
507676.47
Dividends Per Share - Security
N/A
EBITDA
-4.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-8.39
Shares Held By Institutions
4.82M
Shares Outstanding - Current
2.79M
Total Liabilities
7.43M
Total Volume MTD
N/A
Value
N/A
Gain YTD
209.752
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLGL showed earnings on August 15, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a provider of drug delivery solutions
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
7 Golda Meir Street
Phone
+972 89313429
Employees
36
Web
https://www.sol-gel.com